These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35194442)
1. Design, Synthesis and Biological Evaluation of 1,3-Diphenyl-3-(phenylthio)propan-1-ones as New Cytotoxic Agents. Bayanati M; Shahhosseini S; Shirazi FH; Farnam G; Zarghi A Iran J Pharm Res; 2021; 20(4):229-237. PubMed ID: 35194442 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective COX-2 Inhibitors. Bayanati M; Daraei B; Zarghi A Anticancer Agents Med Chem; 2023; 23(2):192-200. PubMed ID: 35692149 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents. Emami L; Sadeghian S; Mojaddami A; Khabnadideh S; Sakhteman A; Sadeghpour H; Faghih Z; Fereidoonnezhad M; Rezaei Z BMC Chem; 2022 Nov; 16(1):91. PubMed ID: 36369166 [TBL] [Abstract][Full Text] [Related]
4. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity. Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents. Kadhim ZY; Alqaraghuli HGJ; Abd MT Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Anticancer Evaluation of 1,4-Naphthoquinone Derivatives Containing a Phenylaminosulfanyl Moiety. Ravichandiran P; Subramaniyan SA; Kim SY; Kim JS; Park BH; Shim KS; Yoo DJ ChemMedChem; 2019 Mar; 14(5):532-544. PubMed ID: 30600915 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors. Mirzaei S; Eisvand F; Hadizadeh F; Mosaffa F; Ghasemi A; Ghodsi R Bioorg Chem; 2020 May; 98():103711. PubMed ID: 32179282 [TBL] [Abstract][Full Text] [Related]
8. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives. Ghanaat J; Khalilzadeh MA; Zareyee D Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134 [TBL] [Abstract][Full Text] [Related]
9. N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Synthesis and cytotoxicity evaluation as anticancer agents. Mohammadi-Farani A; Foroumadi A; Kashani MR; Aliabadi A Iran J Basic Med Sci; 2014 Jul; 17(7):502-8. PubMed ID: 25429341 [TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Pyrrolo[2,1-a]Isoquinoline-Based Derivatives as New Cytotoxic Agents. Kakhki S; Shahosseini S; Zarghi A Iran J Pharm Res; 2016; 15(4):743-751. PubMed ID: 28243270 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic activity of novel poly-substituted imidazo[2,1-c][1,2,4]triazin-6-amines. Akbarzadeh T; Noushini S; Taban S; Mahdavi M; Khoshneviszadeh M; Saeedi M; Emami S; Eghtedari M; Sarrafi Y; Khoshneviszadeh M; Safavi M; Divsalar K; Moshafi MH; Asadipour A; Sabourian R; Edraki N; Firouzi O; Miri R; Shafiee A; Foroumadi A Mol Divers; 2015 May; 19(2):273-81. PubMed ID: 25613858 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt. Abo-Salem HM; Gibriel AA; El Awady ME; Mandour AH Med Chem; 2021; 17(2):158-170. PubMed ID: 32141421 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Cytotoxicity Study of New Cyclopenta [b] quinoline-1,8-dione Derivatives. Miri R; Firuzi O; Peymani P; Nazarian Z; Shafiee A Iran J Pharm Res; 2011; 10(3):489-96. PubMed ID: 24250380 [TBL] [Abstract][Full Text] [Related]
14. Development of potential anticancer agents and apoptotic inducers based on 4-aryl-4H chromene scaffold: Design, synthesis, biological evaluation and insight on their proliferation inhibition mechanism. Elshemy HAH; Zaki MA; Mahmoud AM; Khan SI; Chittiboyina AG; Kamal AM Bioorg Chem; 2022 Jan; 118():105475. PubMed ID: 34800886 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones. Toan DN; Thanh ND; Truong MX; Van DT Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305 [TBL] [Abstract][Full Text] [Related]
17. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids. Zhang YZ; Liu HL; He QS; Xu Z Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237 [TBL] [Abstract][Full Text] [Related]
18. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives. Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494 [TBL] [Abstract][Full Text] [Related]
19. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer. Leclercq G; Devleeschouwer N; Heuson JC J Steroid Biochem; 1983 Jul; 19(1A):75-85. PubMed ID: 6887875 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Biological Evaluation of New 1,3-diphenyl-3- (phenylamino)propan-1-ones as Selective Cyclooxygenase (COX-2) Inhibitors. Farzaneh S; Shahhosseini S; Arefi H; Daraei B; Esfahanizadeh M; Zarghi A Med Chem; 2018; 14(7):652-659. PubMed ID: 29804536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]